Plasma Levels of α-antitrypsin-derived C-terminal Peptides in PiMM and PiZZ COPD Patients

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2023 Dec 11

PMID 38076674

Authors

Friedemann R Borner

Urszula Lechowicz

Sabine Wrenger

Beatriz Martinez-Delgado

Beata Olejnicka

Tobias Welte

Joanna Chorostowska-Wynimko

Michael Kiehntopf

Sabina Janciauskiene

Affiliations

Soon will be listed here.

Abstract

https://bit.ly/3rNJeLd.

Citing Articles

α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review).

Wang T, Shuai P, Wang Q, Guo C, Huang S, Li Y Mol Med Rep. 2025; 31(4).

PMID: 40017119 PMC: 11881679. DOI: 10.3892/mmr.2025.13472.

References

Schnabel C, Harnisch L, Walter D, Blaurock-Moller N, Bauer M, Quintel M . Association of the C-terminal 42-peptide fragment of alpha-1 antitrypsin with the severity of ARDS: A pilot study. Clin Biochem. 2022; 111:41-46. DOI: 10.1016/j.clinbiochem.2022.10.005. View

Wilkinson D, Falconer A, Wright H, Lin H, Yamamoto K, Cheung K . Matrix metalloproteinase-13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha-1 antitrypsin: Implications for osteoarthritis. FEBS J. 2021; 289(1):121-139. DOI: 10.1111/febs.16127. View

Agusti A, Edwards L, Rennard S, MacNee W, Tal-Singer R, Miller B . Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7(5):e37483. PMC: 3356313. DOI: 10.1371/journal.pone.0037483. View

Seersholm N, Kok-Jensen A, Dirksen A . Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med. 1995; 152(6 Pt 1):1922-5. DOI: 10.1164/ajrccm.152.6.8520756. View

Matamala N, Aggarwal N, Iadarola P, Fumagalli M, Gomez-Mariano G, Lara B . Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 Gene. PLoS One. 2017; 12(1):e0170533. PMC: 5249162. DOI: 10.1371/journal.pone.0170533. View

Bigalke A, Sponholz C, Schnabel C, Bauer M, Kiehntopf M . Multiplex quantification of C-terminal alpha-1-antitrypsin peptides provides a novel approach for characterizing systemic inflammation. Sci Rep. 2022; 12(1):3844. PMC: 8907207. DOI: 10.1038/s41598-022-07752-w. View

Janciauskiene S, Welte T . Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments. Ann Am Thorac Soc. 2016; 13 Suppl 4:S280-8. DOI: 10.1513/AnnalsATS.201507-468KV. View

Janciauskiene S, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T . The discovery of α1-antitrypsin and its role in health and disease. Respir Med. 2011; 105(8):1129-39. DOI: 10.1016/j.rmed.2011.02.002. View

MacNee W . Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med. 2012; 45(3):291-300. DOI: 10.3109/07853890.2012.732703. View

10.

Bigalke A, Neu C, Esper Treml R, Coldewey S, Kiehntopf M . Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis. Clin Chem Lab Med. 2022; 60(8):e187-e189. DOI: 10.1515/cclm-2022-0361. View

11.

Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A . Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?. Int J Chron Obstruct Pulmon Dis. 2017; 12:829-837. PMC: 5352160. DOI: 10.2147/COPD.S125240. View

12.

Gerbod-Giannone M, Castillo-Olivares A, Janciauskiene S, Gil G, Hylemon P . Suppression of cholesterol 7alpha-hydroxylase transcription and bile acid synthesis by an alpha1-antitrypsin peptide via interaction with alpha1-fetoprotein transcription factor. J Biol Chem. 2002; 277(45):42973-80. DOI: 10.1074/jbc.M205089200. View

13.

Stockley R . Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med. 1999; 160(5 Pt 2):S49-52. DOI: 10.1164/ajrccm.160.supplement_1.13. View

14.

McCarthy C, Reeves E, McElvaney N . The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. Ann Am Thorac Soc. 2016; 13 Suppl 4:S297-304. DOI: 10.1513/AnnalsATS.201509-634KV. View

15.

Lechowicz U, Rudzinski S, Jezela-Stanek A, Janciauskiene S, Chorostowska-Wynimko J . Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein. Int J Mol Sci. 2020; 21(23). PMC: 7731214. DOI: 10.3390/ijms21239187. View

16.

Janciauskiene S, Wrenger S, Immenschuh S, Olejnicka B, Greulich T, Welte T . The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions. Front Pharmacol. 2018; 9:341. PMC: 5914301. DOI: 10.3389/fphar.2018.00341. View

17.

Blaurock-Moller N, Groger M, Siwczak F, Dinger J, Schmerler D, Mosig A . CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an Liver-on-Chip Model. Front Immunol. 2019; 10:273. PMC: 6401602. DOI: 10.3389/fimmu.2019.00273. View

18.

Ferrarotti I, Thun G, Zorzetto M, Ottaviani S, Imboden M, Schindler C . Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax. 2012; 67(8):669-74. DOI: 10.1136/thoraxjnl-2011-201321. View

19.

Subramaniyam D, Glader P, von Wachenfeldt K, Burneckiene J, Stevens T, Janciauskiene S . C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int J Biochem Cell Biol. 2005; 38(4):563-75. DOI: 10.1016/j.biocel.2005.09.021. View

20.

Piitulainen E, Eriksson S . Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J. 1999; 13(2):247-51. DOI: 10.1183/09031936.99.13224799. View